Clinical Trials Browser

Phase 3 × INDUSTRY × aflibercept × Clear all

NCT00532155 2025-09-10

VITAL

Phase 3 Completed

913 enrolled 16 charts

Carcinoma, Lung Neoplasms

NCT03710564 2023-01-30

MERLIN

Phase 3 Terminated

535 enrolled 14 charts

Macular Degeneration, Neurofibromatosis 2

NCT01571284 2018-04-17

Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen

Phase 3 Completed

781 enrolled 28 charts

Gastrointestinal

Colorectal Cancer Metastatic

NCT01670721 2016-11-28

AFEQT

Phase 3 Completed

175 enrolled 6 charts

Gastrointestinal

Colorectal Cancer Metastatic

NCT01661270 2016-10-18

AFLAME

Phase 3 Completed

332 enrolled 9 charts

Gastrointestinal

Colorectal Cancer Metastatic

NCT00519285 2016-07-22

VENICE

Phase 3 Completed

1,224 enrolled 21 charts

Neoplasm Metastasis, Neoplasms, Prostatic Neoplasms

NCT00574275 2016-06-07

VANILLA

Phase 3 Terminated

546 enrolled 14 charts

Gastrointestinal

Pancreatic Neoplasms

NCT00561470 2012-09-28

VELOUR

Phase 3 Completed

1,226 enrolled 16 charts

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms